A look into Allogene Therapeutics Inc (ALLO)’s deeper side
With 2.58 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.42 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.49 whereas the lowest price it dropped to was $1.38. The 52-week range on ALLO shows […]
Allogene Therapeutics Inc (ALLO) is looking forward to a strong quarter
With 4.86 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.43 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.5 whereas the lowest price it dropped to was $1.36. The 52-week range on ALLO shows […]
Allogene Therapeutics Inc (ALLO) Performance and Fundamentals Dashboard tells a completely different story
With 3.19 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.5 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.45 whereas the lowest price it dropped to was $1.3. The 52-week range on ALLO shows […]
This trade activity should not be overlooked: Allogene Therapeutics Inc (ALLO)
With 1.55 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.57 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.7 whereas the lowest price it dropped to was $1.59. The 52-week range on ALLO shows […]
An analyst sees good growth prospects for Allogene Therapeutics Inc (ALLO)
With 3.34 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.44 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.85 whereas the lowest price it dropped to was $1.69. The 52-week range on ALLO shows […]
Nothing is Better Than Allogene Therapeutics Inc (ALLO) stock at the moment
With 2.8 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.42 million shares. The 52-week range on ALLO shows that it touched its highest point at $5.42 and its lowest point at $1.32 during that stretch. It currently has a 1-year price target of $9.96. Beta for […]
Take off with Allogene Therapeutics Inc (ALLO): Get ready for trading
With 6.05 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.15 million shares. The 52-week range on ALLO shows that it touched its highest point at $5.78 and its lowest point at $1.32 during that stretch. It currently has a 1-year price target of $9.96. Beta for […]
